Explore by Topic
Rituximab vs Ocrelizumab: What MS Patients Need Now
Rituximab vs Ocrelizumab: What MS Patients Need Now

7/2/2026

A 2-year trial found rituximab nearly as effective as ocrelizumab at stopping MRI activity in newly ...

Credibility
Interest
Read More
Heart Health Matters: Tips for MS Patients and Caregivers
Heart Health Matters: Tips for MS Patients and Caregivers

12/2/2025

Learn how managing heart disease risk factors can improve health for MS patients and caregivers. Sim...

Credibility
Interest
Read More
New Insights on Pain Relief for MS Patients
New Insights on Pain Relief for MS Patients

8/28/2025

Learn how understanding acid-sensing channels could lead to better treatments for pain and inflammat...

Credibility
Interest
Read More
New Hope for MS: Tolebrutinib Reduces Disability Progression
New Hope for MS: Tolebrutinib Reduces Disability Progression

4/8/2025

Discover how tolebrutinib may help slow down disability progression in MS patients without relapses,...

Credibility
Interest
Read More
Comparing MS Treatments: Tolebrutinib vs. Teriflunomide
Comparing MS Treatments: Tolebrutinib vs. Teriflunomide

4/8/2025

Learn how tolebrutinib compares to teriflunomide for managing relapsing MS, including effectiveness ...

Credibility
Interest
Read More
How Biomarkers Can Help MS Treatment Choices
How Biomarkers Can Help MS Treatment Choices

4/4/2025

Discover how biomarkers can improve treatment decisions for MS and similar diseases, helping patient...

Credibility
Interest
Read More
New Blood Marker May Help Predict Multiple Sclerosis Early
New Blood Marker May Help Predict Multiple Sclerosis Early

6/7/2024

Discover how a new blood test could predict MS before symptoms start, helping patients manage their ...

Credibility
Interest
Read More
IL-6 blockers lower MOGAD relapses — quick guide
IL-6 blockers lower MOGAD relapses — quick guide

7/13/2026

International study: IL‑6 receptor blockers greatly cut relapses in MOGAD versus before treatment an...

Credibility
Interest
Read More
mRNA therapy retrains the immune system in MS models
mRNA therapy retrains the immune system in MS models

7/6/2026

Animal research shows mRNA-packed nanoparticles can teach the immune system to reduce MS-like damage...

Credibility
Interest
Read More
Spinal-fluid gene drug reaches brain and cuts target protein
Spinal-fluid gene drug reaches brain and cuts target protein

7/6/2026

Autopsy study shows intrathecal gene-targeting drug reaches human brain and spinal cord and lowers a...

Credibility
Interest
Read More